Financial statements Pharmaceutica
Balance sheet data of PHARMACEUTICA
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 646 759,73 | 437 170,30 | 641 250,77 | 897 771,17 | 1 389 206,11 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
B. Current assets | 646 759,73 | 437 170,30 | 641 250,77 | 897 771,17 | 1 389 206,11 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 646 759,73 | 437 170,30 | 641 250,77 | 897 771,17 | 1 389 206,11 |
A. Equity | 82 827,80 | 99 119,70 | 89 402,99 | 152 379,76 | 479 317,42 |
B. Liabilities and provisions for liabilities | 563 931,93 | 338 050,60 | 551 847,78 | 745 391,41 | 909 888,69 |
I. Long-term liabilities | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.